MS sufferers have new drug hope by quango

The first pill for MS sufferers is set to be approved for use on the NHS.The National Institute for Curbing Expendtiture (NICE) has overturned previous draft guidance on the drug Fingolimod after the price was discounted and has now ruled that a proportion of people with multiple sclerosis should be

Read More

Killer quango NICE rejects MS pill as too costly

The Government’s drugs spending watchdog has decided that the first pill to treat multiple sclerosis (MS) is too costly to be prescribed on the NHS.The draft decision dashes the hopes of thousands of sufferers with the auto-immune disease who receive little benefit from current drugs. There was enormous excitement among

Read More

Study backs use of cannabis based Sativex to treat Multiple Sclerosis

The results of a Phase III trial have shown the ability of GW Pharmaceuticals’ cannabinoid based medicine Sativex to reduce severe spasticity associated with Multiple Sclerosis. According to the data, published in the European Journal of Neurology, about half of MS patients who had failed to respond to standard therapy

Read More